<DOC>
	<DOCNO>NCT01133158</DOCNO>
	<brief_summary>Assess combination efficacy combination rituximab , bendamustine , mitoxantrone , dexamethasone treatment patient Follicular Lymphoma .</brief_summary>
	<brief_title>R-BMD GELTAMO Relapsed Lymphoma</brief_title>
	<detailed_description>Assess combination efficacy safety combination rituximab , bendamustine , mitoxantrone , dexamethasone treatment patient Follicular Lymphoma refractory relapse .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Mitoxantrone</mesh_term>
	<mesh_term>Bendamustine Hydrochloride</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>1 . Age ≥ 18 ≤ 75 year . 2 . Patients follicular lymphoma grade 1 , 2 3a , CD20 + , histologically confirm lymph node biopsy tissue . Be accept diagnosis bone marrow accessible lymph node whether discarded mantle LLC , NHL . 3 . Follicular lymphoma patient treat combination rituximab chemotherapy first line , refractory relapse achieved response first line pretreatment ( exclude radiotherapy ) . 4 . ECOG ≤ 2 . 5 . Signed write informed consent . 1 . Clinical suspicion documentation histological transformation . 2 . Have receive prior chemotherapy scheme , first line without Rituximab . 3 . Prior autologous allogeneic . 4 . CNS infiltration LF ( primary CNS lymphoma lymphomatous meningitis ) . 5 . Past active Hepatitis B ( least one follow marker HBsAg , HBe Ag , antiHBc , HBV DNA ) 6 . HCV infection . HIV infection condition serious immunosuppression . 7 . Previous neoplasms except nonmelanoma skin cancer cervix adequately treat . 8 . Cardiac function cardiac patient know prior treatment anthracyclines EF &lt; 50 % . 9 . Impaired renal function ( creatinine &gt; 1.5 x Upper Limit Normal , LSN ) creatinine clearance &lt; 50 ml / h , related lymphoma . 10 . Impaired liver function ( bilirubin , AST / ALT GGT &gt; 2 x ULN ) relate lymphoma . 11 . Women nurse pregnant . Women childbearing potential include prior pregnancy test serum / urine negative . Use effective contraception keep 1 year cessation rituximab . 12 . Patients heart disease , pulmonary , neurological , psychiatric severe metabolic secondary lymphoma . 13 . Severe acute chronic infection activity . 14 . Any concurrent medical psychological comorbidity might interfere participation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Follicular non-Hodgkin 's lymphoma relapse refractory standard first-line immunochemotherapy</keyword>
</DOC>